JournalsHub
.online
Find My Journal
DG

David R. Gandara

Comprehensive Blood & Cancer Center US

ORCID iD 0000-0003-1784-048X
1,113
Publications
54,755
Citations
100
H-Index
465
i10-Index
4.97
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

1,109 total

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial PDF

Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello et al. - The Lancet, 2016
Cited by 4,746 OpenAlex

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste et al. - Journal of Clinical Oncology, 2008
Cited by 3,212 OpenAlex

Research Topics

Lung Cancer Treatments and Mutations (599) Lung Cancer Research Studies (255) Cancer Genomics and Diagnostics (219) Lung Cancer Diagnosis and Treatment (183) Colorectal Cancer Treatments and Studies (130)

Affiliations

Boston University
US 2000 - 2000
Ontario Institute for Cancer Research
CA 2011 - 2009
University of Southern California
US 2009 - 2004
Roche (Switzerland)
CH 2021 - 2021
University of Maryland, Baltimore
US 2008 - 2003

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now